首页> 外文期刊>Der Pharmacia Lettre >Design and evaluation of gemifloxacin mesylate mucoadhesive microspheres
【24h】

Design and evaluation of gemifloxacin mesylate mucoadhesive microspheres

机译:甲磺酸吉非沙星粘膜粘附微球的设计与评价

获取原文
           

摘要

In the present research work mucoadhesive microspheres of Gemifloxacin mesylate was prepared using Ionotropic gelation technique. All the microspheres were characterized for particle size, scanning electron microscopy, FT-IR study, DSC, percentage yield, drug entrapment, stability studies and for in vitro release kinetics and found to be within the limits. Among all the formulations M11 was selected as optimized formulation based on the physic chemical and release studies. In vitro drug release study of optimized formulation M11 showed 98.99% after 12 h in a controlled manner, which is essential for anti ulcer therapy. The innovator Gemiflox conventional tablet shows the drug release of 96.15 within 1 h. The drug release of Gemifloxacin mesylate optimized formulation M11 followed zero order and Higuchi kinetics indicating diffusion controlled drug release.
机译:在本研究工作中,使用离子型凝胶化技术制备了甲磺酸吉米沙星的粘膜粘附微球。所有微球的粒径,扫描电子显微镜,FT-IR研究,DSC,收率百分比,药物截留,稳定性研究以及体外释放动力学均经过了表征,发现均在限制范围内。在所有配方中,根据物理化学和释放研究,选择M11作为优化配方。优化制剂M11的体外药物释放研究显示12 h后以可控方式达到98.99%,这对于抗溃疡治疗至关重要。创新者Gemiflox常规片剂在1小时内显示96.15的药物释放。甲磺酸吉米沙星优化制剂M11的药物释放遵循零级和Higuchi动力学,表明扩散控制药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号